UCB Celltech clinical trials
Acquired by UCB S.A., Jul 6, 2004 · source ↗
The registry lists 8 studies whose lead sponsor is UCB Celltech. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 31, 2021.
Before and after it joined UCB S.A.
- First submitted before UCB Celltech became part of UCB S.A.
- 0
- First submitted after UCB Celltech became part of UCB S.A.
- 8
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- UCB Celltech8 studies
Something wrong with this grouping? Tell us on the UCB S.A. page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All UCB S.A. studies →
- A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy SubjectsCompletedNCT05028127Phase 1
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- UCB Proof of Concept Study in Patients With Primary Sjögren's SyndromeTerminatedNCT02610543Phase 2
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and AdolescentsTerminatedNCT00899678Phase 2
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid ArthritisCompletedNCT02430909Phase 2
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- A First-In-Human Study With a Single Dose UCB7665 in Healthy VolunteersCompletedNCT02220153Phase 1
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- Multiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisCompletedNCT02141763Phase 1
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With PsoriasisCompletedNCT02529956Phase 1
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.
- Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy SubjectsCompletedNCT02207595Phase 1
Sponsor listed in the registry: UCB Celltech · First submitted after UCB Celltech became part of UCB S.A.